Shockwave Medical, Inc.

Shockwave’s IVL platform delivers acoustic pressure waves through an integrated balloon catheter to fracture intimal and medial calcium within the vessel wall, enabling low-pressure balloon expansion and facilitating stent delivery while aiming to minimize vascular injury. Its products are used by interventional cardiologists and vascular specialists and have received regulatory clearances for coronary and peripheral indications in key markets. The company focuses on improving outcomes in complex, heavily calcified lesions that are difficult to treat with conventional angioplasty and atherectomy.